Companies / Australia
Joint Regulatory Agency Shelved
July 2007 | Legal NewsIn a blow to efficiency and a victory for nationalism, plans for a combined Australia/New Zealand agency for the approval of medicines have been deferred until there is more support for the proposal. The main objection was that the new system would raise the price of vitamins and herbal remedies, but BMI argues that it may have reduced the cost of expensive patented pharmaceuticals, as drugmakers would have been persuaded to lower prices given that one less set of registration fees would have to be paid. We are confident that the plan will proceed eventually, given the obvious benefit of
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
